巴杜安金运动对老年人认知障碍的影响:系统性审查和元分析
Xiao-Gang Gong1, Le-Peng Wang2, Ling-Ling Yang3
1Department of Medicine, College of Special Education, Beijing Union University, Beijing, China.
Frontiers in public health
|July 18, 2025
概括
在老年人中,Baduanjin运动显著改善了认知功能,记忆和执行功能. 这种低成本的心身干预措施对管理认知障碍有希望,没有报告的不良影响.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 综合医学是一个整体的医学.
背景情况:
- 老年人认知障碍是一个重大的全球健康挑战,特别是在服务不足的地区.
- 炼Baduanjin是一种传统的中国心身练习,是一种低成本的干预,对认知健康有潜在的益处.
- 目前关于Baduanjin对老年人认知障碍的疗效的证据是不确定的.
研究的目的:
- 系统地评估Baduanjin运动对改善老年人的认知功能的有效性和安全性.
- 综合随机对照试验 (RCT) 的发现,提供关于Baduanjin对认知障碍的影响的共识.
主要方法:
- 在主要数据库中对到2025年1月30日发表的RCT进行了全面的文献搜索.
- 七项涉及539名社区老年人的RCT符合纳入标准.
- 数据提取和质量评估按照PRISMA指南进行,使用Cochrane风险偏差工具.
主要成果:
- 在Baduanjin运动中,总体认知功能 (MD=2.15,p<0.00001),记忆 (SMD=0.59,p<0.00001) 和执行功能 (SMD=0.26,p=0.007) 在统计学上显著改善.
- 参与者也显示了身体健康的显著改善 (MD=-0.86,p<0.00001).
- 在任何包括的研究中都没有报告任何不良影响.
结论:
- 炼Baduanjin是一种有效的干预措施,可以改善老年人的认知障碍.
- 这些发现支持使用Baduanjin作为一种可行的和安全的心身炼来增强老年人的认知健康.
- 建议进一步进行高质量的RCT来巩固这些结论.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.9K
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
1.9K
相关概念视频
01:30Cognitive Development During Adulthood
288
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
288
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262